SCHEMBL9860158

SCHEMBL9860158

C1CC2OC2C1.OI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15842 0.89
SCHEMBL14569692 0.89
SCHEMBL3322733 0.89
SCHEMBL31162289 0.89
SCHEMBL2368206 0.89 KDM4E (0.33)
SCHEMBL4193479 0.86
Methyl Alcohol SCHEMBL8598770 0.86
SCHEMBL18597177 0.85 TFPI2 (0.38)
SCHEMBL8687641 0.85 ALDH1A1 (0.33)
Water SCHEMBL11665768 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4988716-A Inhibitors of slow reacting substance of anaphylaxis SCHERING CORPORATION (US) 1991-01-29 US disclosed
US-4889873-A Inhibitors of slow reacting substance of anaphylaxis SCHERING CORPORATION (US) 1989-12-26 US disclosed
US-4798842-A Inhibitors of slow reacting substance of anaphylaxis SCHERING CORPORATION (US) 1989-01-17 US disclosed
US-4758594-A Inhibitors of slow reacting substance of anaphylaxis SCHERING CORPORATION (US) 1988-07-19 US disclosed
US-4696946-A Topical Treatment of hyperproliferative skin diseases SCHERING CORPORATION (US) 1987-09-29 US disclosed